BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1924484)

  • 1. Conservative surgery of kidney tumors.
    Selli C; Lapini A; Carini M
    Prog Clin Biol Res; 1991; 370():9-17. PubMed ID: 1924484
    [No Abstract]   [Full Text] [Related]  

  • 2. Functional and oncological outcomes of partial nephrectomy of solitary kidneys.
    La Rochelle J; Shuch B; Riggs S; Liang LJ; Saadat A; Kabbinavar F; Pantuck A; Belldegrun A
    J Urol; 2009 May; 181(5):2037-42; discussion 2043. PubMed ID: 19298974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
    Blute ML; Itano NB; Cheville JC; Weaver AL; Lohse CM; Zincke H
    J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tumor involvement of the vena cava in renal cell carcinoma. Surgical technique, results and prognosis].
    Staehler G; Drehmer I; Pomer S
    Urologe A; 1994 Mar; 33(2):116-21. PubMed ID: 8178405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes.
    Parekh DJ; Cookson MS; Chapman W; Harrell F; Wells N; Chang SS; Smith JA
    J Urol; 2005 Jun; 173(6):1897-902. PubMed ID: 15879771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of patients with brain metastases from melanoma and renal cell carcinoma after primary stereotactic radiosurgery.
    Jensen RL; Shrieve AF; Samlowski W; Shrieve DC
    Clin Neurosurg; 2008; 55():150-9. PubMed ID: 19248682
    [No Abstract]   [Full Text] [Related]  

  • 7. [Local recurrence after organ saving kidney tumor surgery].
    Brkovic D; Riedasch G; Waldherr R; Röhl L; Staehler G
    Urologe A; 1994 Mar; 33(2):104-9. PubMed ID: 8178403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of postoperative C-reactive protein level on recurrence and prognosis in patients with N0M0 clear cell renal cell carcinoma.
    Ito K; Yoshii H; Sato A; Kuroda K; Asakuma J; Horiguchi A; Sumitomo M; Asano T
    J Urol; 2011 Aug; 186(2):430-5. PubMed ID: 21679988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral synchronous sporadic renal cell carcinoma: surgical management, oncological and functional outcomes.
    Pahernik S; Cudovic D; Roos F; Melchior SW; Thüroff JW
    BJU Int; 2007 Jul; 100(1):26-9. PubMed ID: 17552949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Conservative elective surgery in kidney neoplasms].
    Ronchi F; Noto O; Stagni S; Innocenti L; D'Aquino N; Paganelli M
    G Chir; 1992 Oct; 13(10):489-92. PubMed ID: 1467149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Kidney parenchyma carcinoma--diagnosis. German Society of Urology].
    Urologe A; 1998 May; 37(3):328-41. PubMed ID: 9646432
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C; Song C; Hong JH; Kim CS; Ahn H
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
    Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG
    J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome of renal cell cancer patients subjected to the simultaneous removal of the primary tumour and an intracaval thrombosis.
    Kuczyk M
    Eur Urol; 2006 Aug; 50(2):310. PubMed ID: 18219721
    [No Abstract]   [Full Text] [Related]  

  • 15. [Conservative surgery for renal carcinoma].
    González Martín M; Alvarez Castelo LM; Chantada Abal V; Rodríguez-Rivera J; Sánchez Merino JM; Gómez Veiga F
    Actas Urol Esp; 1999 May; 23(5):424-31. PubMed ID: 10427817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery.
    Lerner SE; Hawkins CA; Blute ML; Grabner A; Wollan PC; Eickholt JT; Zincke H
    J Urol; 1996 Jun; 155(6):1868-73. PubMed ID: 8618276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes following partial nephrectomy by tumor size.
    Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
    J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conservative surgical treatment of renal cell carcinoma. The University of Miami experience.
    Block NL; Ciancio G
    J Fla Med Assoc; 1995 Sep; 82(9):607-11. PubMed ID: 7595342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.
    Dimarco DS; Lohse CM; Zincke H; Cheville JC; Blute ML
    Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
    Itano NB; Blute ML; Spotts B; Zincke H
    J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.